News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|December 23, 2019

Overview of Cutaneous Squamous Cell Carcinoma Management

Episodes in this series

EP. 1 Overview of Cutaneous Squamous Cell Carcinoma

EP. 1 Overview of Cutaneous Squamous Cell Carcinoma

EP. 2 Overview of Cutaneous Squamous Cell Carcinoma Management

EP. 2 Overview of Cutaneous Squamous Cell Carcinoma Management

EP. 3 Cutaneous Squamous Cell Carcinoma: What Is Immunotherapy?

EP. 3 Cutaneous Squamous Cell Carcinoma: What Is Immunotherapy?

EP. 4 Experience With Immunotherapy in cSCC

EP. 4 Experience With Immunotherapy in cSCC

EP. 5 Decision-Making Surrounding the Treatment of cSCC

EP. 5 Decision-Making Surrounding the Treatment of cSCC

EP. 6 CSCC in the Context of Skin Cancers and Risk Factors

EP. 6 CSCC in the Context of Skin Cancers and Risk Factors

EP. 7 CSCC Diagnosis and Early Stage Definition

EP. 7 CSCC Diagnosis and Early Stage Definition

EP. 8 Advanced Versus Metastatic CSCC

EP. 8 Advanced Versus Metastatic CSCC

EP. 9 CSCC Staging Criteria: Surgery or Systemic Therapy

EP. 9 CSCC Staging Criteria: Surgery or Systemic Therapy

EP. 10 Locally Advanced Disease: I/O or Surgery Decision Factors

EP. 10 Locally Advanced Disease: I/O or Surgery Decision Factors

EP. 11 Anti-PD1 Therapy and CSCC

EP. 11 Anti-PD1 Therapy and CSCC

EP. 12 Immunotherapy in Patients Receiving Organ Transplantation

EP. 12 Immunotherapy in Patients Receiving Organ Transplantation

EP. 13 Multidisciplinary Management of CSCC

EP. 13 Multidisciplinary Management of CSCC

EP. 14 The Future of CSCC Management

EP. 14 The Future of CSCC Management

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Image of Irvin

Getting on My Ovarian Cancer Awareness Soap Box Again Because I Love My Daughter

September 10th 2026

Miguel Gonzales-Velez

Placebos in Cancer Clinical Trials: What Patients Need to Know

ByDr. Miguel Gonzalez-Velez,Kaitlyn M. Le

September 9th 2026

OSTOMY

Why Medicare's Ostomy Supply Changes Concern Cancer Survivors

ByKaitlyn M. Le,Ellyn Mantell

September 9th 2026

Image of Prostate cancer

5 Years of Prostate Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients

ByQuincy Attobrah

September 9th 2026

Image of FDA

FDA Grants Accelerated Approval to Hyrnuo for Certain Patients With HER2-Mutated NSCLC

ByQuincy Attobrah

September 9th 2026

Trending on CURE

5 Years of Prostate Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients

Placebos in Cancer Clinical Trials: What Patients Need to Know

Why Medicare's Ostomy Supply Changes Concern Cancer Survivors

Getting on My Ovarian Cancer Awareness Soap Box Again Because I Love My Daughter